Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Helm

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Vaccine|May 5, 2018
Antibody persistence and booster response 68 months after vaccination at 2-10 years of age with one dose of MenACWY-TT conjugate vaccineMarkus Knuf, Klaus Helm, Devayani Kolhe, et al.
The American Journal of Dermatopathology|May 7, 2015
Lentigo Maligna Melanoma With Local and Distant Blue Nevus-like MetastasesDavid S Baird, Michael D Ioffreda, Klaus Helm, et al.
Frontiers in Pediatrics|March 3, 2023
Safety of <i>Pelargonium</i> extract EPs 7630 in young children with acute bronchitisWolfgang Kamin, Ulrich Behre, Klaus Helm, et al.
Journal of Cutaneous Pathology|February 27, 2023
Cutaneous VCL::ALK fusion ovoid-spindle cell neoplasmMatthew Helm, Allison Chang, Julie C Fanburg-Smith, et al.
Journal of the American Academy of Dermatology|September 13, 2023
Predictive value of excision site bacterial burden and development of surgical site infection: A retrospective cohort studyColleen Silva, Christen Samaan, Norhan Shamloul, et al.
The Journal of Investigative Dermatology|October 16, 2004
Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasmsChristopher J Miller, Mitchell Cheung, Arati Sharma, et al.
European Journal of Pediatrics|September 22, 2011
Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy childrenMarkus Knuf, Fred Zepp, Klaus Helm, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 31, 2004
Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infantsJan Knol, Petra Scholtens, Corinna Kafka, et al.
The Pediatric Infectious Disease Journal|April 2, 2015
An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of agePope Kosalaraksa, Jesper Mehlsen, Timo Vesikari, et al.
BMC Pediatrics|February 9, 2019
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized studySaul N Faust, Maguelone Le Roy, Chitsanu Pancharoen, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Vaccine|May 5, 2018
Antibody persistence and booster response 68 months after vaccination at 2-10 years of age with one dose of MenACWY-TT conjugate vaccineMarkus Knuf, Klaus Helm, Devayani Kolhe, et al.
The American Journal of Dermatopathology|May 7, 2015
Lentigo Maligna Melanoma With Local and Distant Blue Nevus-like MetastasesDavid S Baird, Michael D Ioffreda, Klaus Helm, et al.
Frontiers in Pediatrics|March 3, 2023
Safety of <i>Pelargonium</i> extract EPs 7630 in young children with acute bronchitisWolfgang Kamin, Ulrich Behre, Klaus Helm, et al.
Journal of Cutaneous Pathology|February 27, 2023
Cutaneous VCL::ALK fusion ovoid-spindle cell neoplasmMatthew Helm, Allison Chang, Julie C Fanburg-Smith, et al.
Journal of the American Academy of Dermatology|September 13, 2023
Predictive value of excision site bacterial burden and development of surgical site infection: A retrospective cohort studyColleen Silva, Christen Samaan, Norhan Shamloul, et al.
The Journal of Investigative Dermatology|October 16, 2004
Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasmsChristopher J Miller, Mitchell Cheung, Arati Sharma, et al.
European Journal of Pediatrics|September 22, 2011
Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy childrenMarkus Knuf, Fred Zepp, Klaus Helm, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 31, 2004
Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infantsJan Knol, Petra Scholtens, Corinna Kafka, et al.
The Pediatric Infectious Disease Journal|April 2, 2015
An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of agePope Kosalaraksa, Jesper Mehlsen, Timo Vesikari, et al.
BMC Pediatrics|February 9, 2019
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized studySaul N Faust, Maguelone Le Roy, Chitsanu Pancharoen, et al.
Pageof 4